AI holds potential to transform pharmacovigilance. But navigating the risks requires critical assessment. This article explores AI's evolving role in medicines safety.

ISoP's 15th annual meeting in Prague, Czech Republic, in October 2015 had an unusual theme – Cubism in Pharmacovigilance, inspired by the Czech cubism movement in the early 1900s.

The partnership seeks to improve the interoperability of CDISC standards and WHODrug Global for more effective sharing and use of medicinal product safety data.

WHO and UMC introduce new VigiBase access conditions, enhancing data sharing clarity and stakeholder confidence in global pharmacovigilance.